RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 142 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11 | -100.0% | 7 | -100.0% | 0.00% | – |
| Q3 2022 | $143,000 | +5.1% | 120,969 | +0.7% | 0.00% | – |
| Q2 2022 | $136,000 | -66.7% | 120,074 | -12.1% | 0.00% | – |
| Q1 2022 | $409,000 | +21.0% | 136,661 | +7.0% | 0.00% | – |
| Q4 2021 | $338,000 | -24.9% | 127,750 | +3.0% | 0.00% | – |
| Q3 2021 | $450,000 | -1.7% | 123,983 | +17.8% | 0.00% | – |
| Q2 2021 | $458,000 | -18.4% | 105,290 | -35.7% | 0.00% | – |
| Q1 2021 | $561,000 | -52.4% | 163,820 | -51.3% | 0.00% | -100.0% |
| Q4 2020 | $1,179,000 | +28.3% | 336,680 | -12.1% | 0.00% | 0.0% |
| Q3 2020 | $919,000 | +210.5% | 383,225 | +137.4% | 0.00% | – |
| Q2 2020 | $296,000 | +19.8% | 161,425 | +1.5% | 0.00% | – |
| Q1 2020 | $247,000 | -63.8% | 159,020 | -50.1% | 0.00% | – |
| Q4 2019 | $683,000 | +19.0% | 318,858 | +4.0% | 0.00% | – |
| Q3 2019 | $574,000 | -14.2% | 306,618 | +19.4% | 0.00% | -100.0% |
| Q2 2019 | $669,000 | +49.3% | 256,715 | +47.2% | 0.00% | – |
| Q1 2019 | $448,000 | -10.6% | 174,456 | -19.9% | 0.00% | -100.0% |
| Q4 2018 | $501,000 | -2.3% | 217,809 | +36.4% | 0.00% | – |
| Q3 2018 | $513,000 | -79.4% | 159,645 | -81.9% | 0.00% | -100.0% |
| Q2 2018 | $2,495,000 | +333.9% | 881,685 | +442.4% | 0.00% | +100.0% |
| Q1 2018 | $575,000 | -29.6% | 162,550 | -22.9% | 0.00% | 0.0% |
| Q4 2017 | $817,000 | +266.4% | 210,751 | +139.4% | 0.00% | – |
| Q3 2017 | $223,000 | -33.4% | 88,030 | -28.4% | 0.00% | – |
| Q2 2017 | $335,000 | -58.9% | 122,980 | -50.1% | 0.00% | -100.0% |
| Q1 2017 | $816,000 | -47.3% | 246,476 | -62.1% | 0.00% | -50.0% |
| Q4 2016 | $1,547,000 | +106.8% | 649,790 | +219.0% | 0.00% | +100.0% |
| Q3 2016 | $748,000 | +206.6% | 203,702 | +85.9% | 0.00% | – |
| Q2 2016 | $244,000 | +221.1% | 109,602 | +200.1% | 0.00% | – |
| Q1 2016 | $76,000 | -82.2% | 36,523 | -74.0% | 0.00% | – |
| Q4 2015 | $426,000 | +213.2% | 140,517 | +154.0% | 0.00% | – |
| Q3 2015 | $136,000 | -23.2% | 55,321 | +0.2% | 0.00% | – |
| Q2 2015 | $177,000 | +32.1% | 55,211 | +46.9% | 0.00% | – |
| Q1 2015 | $134,000 | +36.7% | 37,596 | -13.2% | 0.00% | – |
| Q4 2014 | $98,000 | -58.6% | 43,297 | -64.7% | 0.00% | – |
| Q3 2014 | $237,000 | +9.2% | 122,485 | +105.3% | 0.00% | – |
| Q2 2014 | $217,000 | -55.2% | 59,669 | -52.1% | 0.00% | – |
| Q1 2014 | $484,000 | -23.3% | 124,631 | -43.7% | 0.00% | -100.0% |
| Q4 2013 | $631,000 | +78.2% | 221,223 | +124.0% | 0.00% | – |
| Q3 2013 | $354,000 | -68.1% | 98,747 | -70.3% | 0.00% | -100.0% |
| Q2 2013 | $1,109,000 | +20.0% | 332,186 | +144.1% | 0.00% | 0.0% |
| Q1 2013 | $924,000 | – | 136,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |